Safety and efficacy of ciprofol for sedation in intensive care unit patients with fiberoptic bronchoscopy

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2200065437

Enrollment

Unknown

Registered

2022-11-04

Start date

2022-11-15

Completion date

Unknown

Last updated

2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

patients with fiberoptic bronchoscopy

Interventions

C group:ciprofol

P group:propofol

Eligibility

Sex/Gender

Male

Age

18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18-80 years, male or female; those who signed informed consent; 2. In intensive care unit patients with fiberoptic bronchoscopy; 3. 18 kg/m2 <= BMI <= 30 kg/m2; 4. Sign informed consent.

Exclusion criteria

Exclusion criteria: 1. Patients with moderate coma caused by craniocerebral injury or cerebrovascular accident; 2. Patients with previous mental diseases.

Design outcomes

Primary

Measure	Time frame
HR, heart rate;BP, blood pressure;RR, respiratory rate;SpO2;Body movement response;days of ICU stay;mortality;	—

Countries

China

Contacts

Public ContactGao Jianling

Dushu Lake Hospital Affiliated to Soohow University

571177307@qq.com+86 13771815313

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026